Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

ELEPSIA XR

LEVETIRACETAM

Standard Dose
1GM
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview ELEPSIA XR is listed in Drugs@FDA under application 204417 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVETIRACETAM Form and strength TABLET, EXTENDED RELEASE;ORAL - 1GM Sponsor TRIPOINT Submission history Latest submission status date: 2024-03-12 00:00:00.

Structured Monograph

Clinical summary

Approval overview ELEPSIA XR is listed in Drugs@FDA under application 204417 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient LEVETIRACETAM Form and strength TABLET, EXTENDED RELEASE;ORAL - 1GM Sponsor TRIPOINT Submission history Latest submission status date: 2024-03-12 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
ELEPSIA XR (LEVETIRACETAM) | Drug Monograph | MedicHelpline